Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Mifepristone Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Mifepristone Manufacturers in India Suppliers Mifepristone Dossage Exporters Distributors Mifepristone api active pharmaceuticals ingredients Mifepristone manufacturers Side Effects bulk drugs raw material Dossage Mifepristone companies Side Effects Dossage Importers Mifepristone Dossage Mifepristone Exporters Mifepristone exporters Dossage FDA Dossage Mifepristone Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Mifepristone manufacturing pharmaceutical drugs pharmaceutical intermediates Mifepristone pharmaceutical chemicals pharmaceutical raw materials Mifepristone active pharmaceutical ingredients Mifepristone committee active pharmaceutical ingredients manufacturer Mifepristone Active Pharmaceutical Ingredients manufacturer Mifepristone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Mifepristone, Mifepristone manufacturer India, Mifepristone product, Mifepristone products, Api preparation, Certificate of Analysis API manufacturer product, Mifepristone anti ulcer product, Certificate of Origin COA Mifepristone COS Mifepristone, pharmaceutical generic, pharmaceutical drug, medical, Mifepristone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Mifepristone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Mifepristone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Mifepristone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Mifepristone ingredients, api, HIV Mifepristone, tablets, capsules, syrup & protein Mifepristone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Mifepristone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Mifepristone WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Chemical Taj Pharmaceuticals Ltd.












 

 










 

 

HOME >> API >> API List 2 >> Mifepristone >> Dosage

Mifepristone

DOSAGE
Mifepristone CAS Number 84371-65-3

Treatment with Mifeprex and misoprostol for the termination of pregnancy requires three office visits by the patient. Mifeprex should be prescribed only by physicians who have read and understood the prescribing information. Mifeprex may be administered only in a clinic, medical office, or hospital, by or under the supervision of a physician, able to assess the gestational age of an embryo and to diagnose ectopic pregnancies. Physicians must also be able to provide surgical intervention in cases of incomplete abortion or severe bleeding, or have made plans to provide such care through others, and be able to assure patient access to medical facilities equipped to provide blood transfusions and resuscitation, if necessary.
Day One: Mifeprex Administration

Patients must read the MEDICATION GUIDE and read and sign the PATIENT AGREEMENT before Mifeprex is administered.

Three 200 mg tablets (600 mg) of Mifeprex are taken in a single oral dose.
Day Three: Misoprostol Administration
The patient returns to the health care provider two days after ingesting Mifeprex. Unless abortion has occurred and has been confirmed by clinical examination or ultrasonographic scan, the patient takes two 200 μg tablets (400 μg) of misoprostol orally.
Day 14: Post-Treatment Examination

Patients will return for a follow-up visit approximately 14 days after the administration of Mifeprex. This visit is very important to confirm by clinical examination or ultrasonographic scan that a complete termination of pregnancy has occurred.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Mifepristone

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.